🔴 GH Research is trading at 5.6% down today as oil, yields and inflation concerns pressure markets

GH Research is trading 5.62% lower at $26.30, primarily amid broad risk-off pressure across markets.

• Major U.S. indexes are lower as oil, Treasury yields, inflation concerns and geopolitical uncertainty weigh on risk assets. Biotech’s overall advance suggests sector weakness is not the main driver.
• No new company-specific announcement was identified on September 23, 2026. Investor-relations materials list previously issued releases, while recent coverage remains focused on FDA progress and the planned Phase 3 path for GH001.